Reticular

Interpretable AI for drug discovery

San Francisco, United States · Founded 2024 · $500K raised

Employees
1–10
Founded
2024
Total Funding
$500K
Last Round
$500K Pre-SeedNov 2024
Rounds
1

About

Reticular helps pharma companies discover drugs with AI models like AlphaFold by making them steerable, just like you can prompt LLMs. Today, limited validation data means companies spend millions on failed experiments trying to steer these models through trial and error. We’re piloting our AI interpretability technology with early-stage biotechs and scaling rapidly. Just a week after our pivot, we identified the first interpretable features ever found in protein models, allowing precise control over biological functions. Nithin and John met competing in Biology Olympiads before spending 4 years as roommates at MIT publishing ML/bio research in NeurIPS and Nature. We believe biological models encode far more information than anyone is currently using - our goal is to unlock this potential.

Summary

Reticular is a Biotech company based in San Francisco, United States, founded in 2024. It has raised $500K in total across 1 round, most recently a $500K Pre-Seed round in Nov 2024. Investors include Y Combinator Continuity Fund, BoxGroup and CRV (Charles River).

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Pre-seedPre-SeedNov 2024
$500K

Investors

Similar Companies